Olmevac-H 40/12.5 Tablet
Marketer
Prevego Healthcare & Research Private Limited
Salt Composition
Hydrochlorothiazide (12.5mg) + Olmesartan Medoxomil (40mg)
Overview Olmevac-H 40/12.5 Tablet
Olmevac-H 40/12.5mg tablets combine two medications to effectively manage hypertension through diverse mechanisms. Untreated high blood pressure significantly increases the risk of serious complications like heart attacks, strokes, and kidney failure. This medication can be taken with or without food, the dosage being determined by individual needs and response. Consistent daily timing is crucial for optimal results; continued use, as directed by your physician, is essential. Containing a diuretic, increased urination is expected; therefore, avoid late-evening administration (within four hours of bedtime). Regular use, even during symptom-free periods, maximizes therapeutic benefits. High blood pressure often presents without noticeable symptoms, and discontinuation raises stroke or heart attack risks. Common side effects include dizziness, weakness, headache, fatigue, chest pain, and swelling. Increased urination is a normal consequence of the diuretic, not an adverse reaction. While other side effects are possible, most are infrequent. Elevated eye pressure, potentially causing irreversible damage if untreated, is a rare but serious possibility. Always review the accompanying patient information leaflet and report any persistent or bothersome side effects to your doctor; dosage adjustments or alternative treatments might be considered. Consult your physician before using this medication if pregnant, breastfeeding, or if you have kidney, liver, cardiac, or diabetic conditions. Alcohol consumption can further reduce blood pressure, potentially exacerbating side effects.
Primary Ingredients of Olmevac-H 40/12.5 Tablet
No information provided. Please provide the text you wish me to rephrase.
Uses of Olmevac-H 40/12.5 Tablet
Elevated arterial blood pressure
Major Benefits of Olmevac-H 40/12.5 Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for Olmevac-H 40/12.5 Tablets. Ingest the tablet whole; do not break, crush, or chew it. While consumption with or without food is acceptable, consistent daily timing is recommended.
Common Side effects of Olmevac-H 40/12.5 Tablet:
- Dizziness
- Weakness
- Tiredness
- Edema (swelling)
- Chest pain
- Upper respiratory tract infection
- Headache
- Increased triglyceride level in blood
- Increased uric acid level in blood
- Abdominal pain
- Back pain
- Skeletal pain
- Blood in urine
- Increased liver enzymes
- Increased blood urea
How to use Olmevac-H 40/12.5 Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Olmevac-H 40/12.5 may be administered with or without food, though consistent timing is recommended.
How Olmevac-H 40/12.5 Tablet works:
Each Olmevac-H 40/12.5 tablet contains a dual formulation of two active pharmaceutical ingredients.
SAFETY ADVICE
AlcoholUNSAFE
Concomitant use of Olmevac-H 40/12.5 tablets and alcohol can lead to increased sleepiness.
PregnancyCONSULT YOUR DOCTOR
Use of Olmevac-H 40/12.5 tablets is contraindicated during pregnancy due to established risks to the fetus. In exceptional, life-threatening circumstances, a physician may deem its use necessary if the potential benefits outweigh the known hazards. Always seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Breastfeeding mothers can likely use Olmevac-H 40/12.5 tablets safely. Available human data indicate minimal risk to the infant.
DrivingUNSAFE
Taking Olmevac-H 40/12.5 tablets may cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these side effects.
KidneyCAUTION
Patients with severe kidney impairment should use Olmevac-H 40/12.5mg tablets cautiously, potentially requiring dosage modification. Physician consultation is recommended. Consistent blood pressure checks are advised to guide dosage adjustments.
LiverCAUTION
Patients with liver impairment should use Olmevac-H 40/12.5 tablets cautiously, potentially requiring dosage modification. Physician consultation is advised.
What if you forget to take Olmevac-H 40/12.5 Tablet :
Should you forget to take your Olmevac-H 40/12.5 Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Olmevac-H 40/12.5 Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Heart |




